Lighting up the path to a better neural future to improve peoples’ lives.
We’re inventing breakthrough neuroelectronic therapies to help mankind solve the neural challenge.
%
of world population is affected by neural disorders
— Prev Med Rep. 2018 Dec & Lancet Neurol 2019
They are the leading cause of disability and the 2nd cause of mortality worldwide.
— World Health Organization, 2022
Incurring an annual cost for society exceeding cost of cancer and cardiovascular diseases combined.
— World Health Organization, 2022
Current neuroelectronic therapies are invasive, low-resolution and generic.
Recharging patients' lives
Our end-to-end neural platform combines hardware and data analytics to decode & modulate neural networks, maximize time on therapy and effectively restore function or mobility for patients.
-
Skin-like, bi-directional, high resolution (up to 1024 contacts) brain-computer interfaces (BCI) enabling real-time smart neural decoding and modulation in closed loop.
-
Implantable compact neural processor with wireless rechargeable battery, powering signal processing.
-
AI-powered platform empowering patients and clinicians to harness their own data through therapy personalization, focusing on improving the outcomes that matter to patients.
-
Our platform has received FDA Breakthrough Device Designation for use in Parkinson’s Disease.
A spark of genius
Harnessing the potential of Graphene, we power up science and technology to decode the brain and revolutionize neural disorders treatment.
We’re on a mission to decode and modulate the brain, but also the entire neural system.
A team of live wires
We are a team of highly experienced materials and neurotech believers, backed by leading tech and scientific advisors.
Latest news
-
Revolutionizing Brain-Computer Interfaces via Groundbreaking Graphene Technology
January 23, 2024
We are thrilled to share that the GphT-BCI project, led by INBRAIN Neuroelectronics in collaboration with Institut Català de Nanociència i Nanotecnologia (ICN2), is set to revolutionize brain-computer interface (BCIs) through groundbreaking graphene technology.
-
Elon Musk’s Neuralink is being outperformed by this Spanish graphene startup
August 11, 2023
Inbrain’s neural implants will be used to treat conditions like Parkinson’s and epilepsy.
-
Inbrain Neuroelectronics and Merck KGaA collaborate to develop the next generation of bioelectronic
July 8, 2023
Joint development agreement represents a promising step towards a highly selective and efficient next generation of bioelectronic therapies powered by graphene
-
11 medical device startups to watch, according to investors
July 1, 2023
Inbrain develops tiny neuro-electronics — miniature interfaces that connect the nervous system with electronic devices — as next-generation neural disease solutions, which represents huge market potential with advanced material science